IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

MWG Management Ltd.

Q2 2025 Holdings

Filed 2025-08-14 | 3 holdings | $51.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Beam Therapeutics Inc(BEAM)COM07373V105$38.6M2,266,93474.3%
Lyell Immunopharma IncCOM55083R104$8.9M1,008,11617.2%
Prime Medicine Inc(PRME)COM74168J101$4.4M1,792,2108.5%